Cargando…
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
Bronchodilators, including long-acting β(2)-agonists and long-acting muscarinic antagonists, are the mainstay for treatment of patients with chronic obstructive pulmonary disease (COPD) to prevent exacerbations or reduce symptoms. Formoterol is a highly selective and potent β(2)-agonist that relaxes...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708267/ https://www.ncbi.nlm.nih.gov/pubmed/33273813 http://dx.doi.org/10.2147/COPD.S273497 |